14-day Premium Trial Subscription Try For FreeTry Free
FRA:BV3
Delisted

Bavarian Nordic A/S Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
20.64€
+0 (+0%)
At Close: Dec 22, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 20.64€ 20.64€ Friday, 22nd Dec 2023 BV3.F stock ended at 20.64€. During the day the stock fluctuated 0% from a day low at 20.64€ to a day high of 20.64€.
90 days 20.18€ 21.17€
52 weeks 18.20€ 35.60€

Historical Bavarian Nordic A/S prices

Date Open High Low Close Volume
May 26, 2023 26.14€ 26.14€ 25.45€ 25.45€ 0
May 25, 2023 26.74€ 26.83€ 26.24€ 26.24€ 0
May 24, 2023 26.66€ 26.66€ 26.66€ 26.66€ 0
May 23, 2023 27.80€ 27.80€ 26.97€ 26.97€ 0
May 22, 2023 27.95€ 27.95€ 27.50€ 27.50€ 0
May 19, 2023 27.50€ 28.10€ 27.50€ 27.61€ 43
May 18, 2023 27.80€ 27.80€ 27.80€ 27.80€ 0
May 17, 2023 28.34€ 28.34€ 27.62€ 27.62€ 0
May 16, 2023 28.49€ 28.51€ 28.49€ 28.51€ 0
May 15, 2023 28.06€ 28.06€ 28.00€ 28.00€ 0
May 12, 2023 28.35€ 28.35€ 27.90€ 27.90€ 0
May 11, 2023 27.02€ 28.12€ 27.02€ 27.71€ 0
May 10, 2023 26.04€ 27.12€ 26.04€ 27.12€ 0
May 09, 2023 25.88€ 26.21€ 25.82€ 26.21€ 0
May 08, 2023 24.75€ 25.13€ 24.75€ 25.13€ 0
May 05, 2023 24.30€ 24.52€ 24.30€ 24.52€ 0
May 04, 2023 23.75€ 24.18€ 23.75€ 24.18€ 0
May 03, 2023 24.41€ 24.41€ 23.33€ 23.33€ 0
May 02, 2023 25.26€ 25.26€ 24.41€ 24.41€ 0
Apr 28, 2023 24.46€ 24.61€ 24.46€ 24.46€ 0
Apr 27, 2023 24.72€ 24.72€ 24.62€ 24.62€ 0
Apr 26, 2023 25.54€ 25.54€ 25.54€ 25.54€ 0
Apr 25, 2023 24.89€ 25.45€ 24.80€ 24.80€ 0
Apr 24, 2023 25.48€ 25.48€ 25.48€ 25.48€ 0
Apr 21, 2023 24.91€ 25.04€ 24.91€ 25.04€ 0
Click to get the best stock tips daily for free!

About Bavarian Nordic A/S

Bavarian Nordic A/S Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BV3.F Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT